Arteris (AIP) CEO sells 50,000 shares via Bayview Legacy 10b5-1 plan

Rhea-AI Filing Summary

Arteris, Inc. President and CEO Charles K. Janac reported open-market sales of a total of 50,000 shares of common stock through Bayview Legacy, LLC on March 9–10, 2026. The shares were sold at weighted average prices of $14.2104 and $14.663 per share.

These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2025. After the sales, indirect holdings through Bayview Legacy, LLC were 9,229,071 shares, in addition to 217,538 shares held directly and 56,252 shares held via the Charles and Lydia Janac Trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JANAC K CHARLES

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		S(1)		41,000	D	$14.2104(2)	9,238,071	I	Bayview Legacy, LLC(3)
Common Stock	03/10/2026		S(1)		9,000	D	$14.663(4)	9,229,071	I	Bayview Legacy, LLC(3)
Common Stock								217,538	D
Common Stock								56,252	I	Charles and Lydia Janac Trust(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.63 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.

4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.35 to $14.90 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for JANAC K CHARLES	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Arteris (AIP) shares did CEO Charles Janac sell in this Form 4?

Charles K. Janac reported selling 50,000 shares of Arteris common stock through Bayview Legacy, LLC. The transactions occurred on March 9–10, 2026, and were disclosed as open-market sales on a Form 4 insider trading report.

At what prices were the Arteris (AIP) shares sold by Bayview Legacy, LLC?

The reported sales used weighted average prices of $14.2104 per share on March 9, 2026, and $14.663 per share on March 10, 2026. Footnotes note the shares were sold in multiple trades within specified intraday price ranges.

Were Charles Janac’s Arteris (AIP) share sales made under a 10b5-1 trading plan?

Yes. A footnote states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2025. Such plans pre-schedule trades to reduce discretion over timing.

How many Arteris (AIP) shares does Charles Janac hold after these transactions?

After the reported sales, indirect holdings via Bayview Legacy, LLC were 9,229,071 shares. The Form 4 also lists 217,538 shares held directly and 56,252 shares held indirectly through the Charles and Lydia Janac Trust.

Who actually held the Arteris (AIP) shares sold in this Form 4?

The 50,000 sold shares were held by Bayview Legacy, LLC. A footnote explains Charles K. Janac is the manager of Bayview Legacy, LLC and is deemed to have voting and dispositive power over its beneficially owned Arteris shares.

What indirect ownership structures are disclosed for Charles Janac’s Arteris (AIP) holdings?

The filing shows indirect holdings through Bayview Legacy, LLC and the Charles and Lydia Janac Trust. Janac is manager of Bayview Legacy, LLC and serves as trustee of the trust, giving him voting and dispositive power over those Arteris shares.